Measured Wealth Private Client Group’s LumiraDx Limited Common Shares LMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-50,000
Closed -$23.3K 200
2023
Q1
$23.3K Hold
50,000
0.01% 173
2022
Q4
$45K Buy
+50,000
New +$52.7K 0.02% 164
2022
Q3
Sell
-30,000
Closed -$80K 190
2022
Q2
$80K Buy
+30,000
New +$120K 0.04% 174

Other funds holding LMDX

Measured Wealth Private Client Group's LMDX Position: Q2 2023 in Review

Measured Wealth Private Client Group sold out of LumiraDx Limited Common Shares (LMDX) in Q2 2023, closing a stake of 50,000 shares — an estimated $23.3K sold.

Measured Wealth Private Client Group first reported a position in LMDX in Q2 2022 and held it in 3 quarters. The position peaked at $80K in Q2 2022. 35 funds tracked by Wall St. Rank hold LMDX as of Q2 2023.

  • Measured Wealth Private Client Group reported no remaining LumiraDx Limited Common Shares position as of Q2 2023 after selling out during the quarter.
  • Measured Wealth Private Client Group sold 50,000 LumiraDx Limited Common Shares shares in Q2 2023, an estimated $23.3K.
  • Measured Wealth Private Client Group first reported a position in LumiraDx Limited Common Shares in Q2 2022 and held it in 3 quarters.
  • Measured Wealth Private Client Group's LumiraDx Limited Common Shares position peaked at $80K in Q2 2022.
  • 35 funds tracked by Wall St. Rank held LumiraDx Limited Common Shares as of Q2 2023.

Based on Measured Wealth Private Client Group's 13F filing for Q2 2023, filed 20 Jul 2023.